Exchange: NASDAQ·Updated 07:30 PM EST

About ALMS

About

Alumis, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. It focuses on building a pipeline of molecules with the potential to address a broad range of immune-mediated diseases such as monotherapy or combination therapies. The company was founded on January 29, 2021 and is headquartered in San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
224

Frequently Asked Questions

Advertisement|Remove ads.